Bionano Genomics, Inc. — Director's Dealing 2021

Jun 14, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bionano Genomics, Inc (BNGO)
CIK: 0001411690
Period of Report: 2021-06-10

Reporting Person: Mamuszka Hannah (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-10	Stock Option (right to buy)	$7.64	A	7528	Acquired	2031-06-10	Common Stock (7528)	Direct

Footnotes

F1: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan).